Surgical Treatment of Pancreatic Cancer: a Follow-Up Study in 216 Cases
郑树森,李启勇,黄东胜,梁廷波,王伟林,张珉,沈岩,吴健,徐骁,严盛,俞军,朱伟芳
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2003.03.003
2003-01-01
Abstract:Objective To investigate the effects of various treatments for pancreatic cancer on survival of patients and summarize the experience in treatment of the disease. Methods The clinical data of 216 patients with pancreatic cancer treated in our hospital between 1990 and 2000 were retrospectively analyzed. All the patients were followed up. SPSS10 0 software package was used for statistical analysis. Meanwhile, Kaplan Meier method and log rank test were used. Results In 169 patients who had been operated on, the surgical resection rate was 40 24% and radical resection rate 31 36%. The median survival time in patients undergoing radical resection, palliative surgical resection, bypass, surgical exploration and none of operations was 304, 138, 134, 123 and 86 d, respectively. The 1 , 3 and 50 year survival rates in patients receiving radical resection were 44 71%, 14 98% and 9 99%, respectively. The 1 , 3 and 5 year survival rates in patients with pancreatic cancer of stage I and II after radical resection were 69 23%, 38 46% and 12 82%, respectively. We have adopted the method of systemic evaluation and standard surgical exploration since 1995. As a result, the surgical resection rate was up to 50 88%, radical resection rate to 38 60% and the 5 year survival rate in patients receiving radical resection to 12 93%. Conclusions Only radical resection is an effective method and palliative treatment can not prolong the lives of patients. The single surgical treatment for pancreatic cancer is dismal and a more effective treatment model should be established.